“I Want to Do It, But I Want to Make Sure That I Do It Right.” Views of Patients with Parkinson’s Disease Regarding Early Stem Cell Clinical Trial Participation

, &
AJOB Empirical Bioethics 11 (3):160-171 (2020)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1080/23294515.2020.1775721

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,202

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Benefits, risks and ethical considerations in translation of stem cell research to clinical applications in Parkinson's disease.Z. Master, M. McLeod & I. Mendez - 2007 - Journal of Medical Ethics 33 (3):169-173.
Target Populations for First-In-Human Embryonic Stem Cell Research in Spinal Cord Injury.Frederic Bretzner, Frederic Gilbert, Françoise Baylis & Robert M. Brownstone - 2011 - Cell Stem Cell 8 (5):468-475.
Resolving Ethical Issues in Stem Cell Clinical Trials: The Example of Parkinson Disease.Bernard Lo & Lindsay Parham - 2010 - Journal of Law, Medicine and Ethics 38 (2):257-266.
Potential Subjects’ Responses to an Ethics Questionnaire in a Phase I Study of Deep Brain Stimulation in Early Parkinson’s Disease.Stuart G. Finder, Mark J. Bliton, Chandler E. Gill, Thomas L. Davis, Peter E. Konrad & P. D. Charles - 2012 - Journal of Clinical Ethics 23 (3):207-216.
Ethics Surrounding Human Embryonic Stem Cell Research.Joseph Nkang Ogar - 2019 - International Social Mentality and Researcher Thinkers Journal 5 (22).
Refining Ethical Guidelines for Early Clinical Trials of Pluripotent Stem-Cell-Derived Therapeutics for Parkinson's Disease.Audrey R. Chapman - 2015 - American Journal of Bioethics Neuroscience 6 (1):65-66.
Bringing prosocial values to translational, disease-specific stem cell research.Reuben G. Sass - 2014 - BMC Medical Ethics 15 (1):16.
Evaluating the First-in-Human Clinical Trial of a Human Embryonic Stem Cell-Based Therapy.Audrey R. Chapman & Courtney C. Scala - 2012 - Kennedy Institute of Ethics Journal 22 (3):243-261.
Resolving Ethical Issues in Stem Cell Clinical Trials: The Example of Parkinson Disease.Bernard Lo & Lindsay Parham - 2010 - Journal of Law, Medicine and Ethics 38 (2):257-266.
Uncertain translation, uncertain benefit and uncertain risk: Ethical challenges facing first-in-human trials of induced pluripotent stem (ips) cells.Ronald K. F. Fung & Ian H. Kerridge - 2011 - Bioethics 27 (2):89-96.
Allowing Innovative Stem Cell-Based Therapies Outside of Clinical Trials: Ethical and Policy Challenges.Insoo Hyun - 2010 - Journal of Law, Medicine and Ethics 38 (2):277-285.
An intervention to improve cancer patients' understanding of early-phase clinical trials.Nancy E. Kass, Jeremy Sugarman, Amy M. Medley, Linda A. Fogarty, Holly A. Taylor, Christopher K. Daugherty, Mark R. Emerson, Steven N. Goodman, Fay J. Hlubocky & Herbert I. Hurwitz - 2009 - IRB: Ethics & Human Research 31 (3):1.
Regulatory Misconception Muddies the Ethical Waters: Challenges to a Qualitative Study.Kimberly M. Yee & Paul J. Ford - 2012 - Journal of Clinical Ethics 23 (3):217-220.
“You are our only hope”: Trading metaphorical “magic bullets” for stem cell “superheroes”.Lawrence Burns - 2009 - Theoretical Medicine and Bioethics 30 (6):427-442.
Unproven stem cell–based interventions and achieving a compromise policy among the multiple stakeholders.Kirstin R. W. Matthews & Ana S. Iltis - 2015 - BMC Medical Ethics 16 (1):1-11.

Analytics

Added to PP
2020-06-10

Downloads
20 (#720,454)

6 months
7 (#339,156)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Inmaculada de Melo-Martin
Weill Cornell Medicine--Cornell University

Citations of this work

No citations found.

Add more citations

References found in this work

Add more references